NASDAQ:STRO | Operating Income | SUTRO BIOPHARMA, INC.

Complete source-backed operating income history.

Available history
2016-12-31 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$29.89M
2026-03-31-$29.66M
2025-12-31-$38.05M
2025-09-30-$48.46M
2025-06-30-$3.35M
2025-03-31-$68.51M
2024-12-31-$65.26M
2024-09-30-$67.92M
2024-06-30-$48.69M
2024-03-31-$56.59M
2023-12-31$43.15M
2023-09-30-$44.01M
2023-06-30-$46.18M
2023-03-31-$42.24M
2022-12-31-$49.22M
2022-09-30-$21.21M
2022-06-30-$19.38M
2022-03-31-$39.13M
2021-12-31-$35.04M
2021-09-30-$34.67M
2021-06-30-$9.81M
2021-03-31-$19.01M
2020-12-31-$24.84M
2020-09-30-$10.62M
2020-06-30-$16.42M
2020-03-31-$19.18M
2019-12-31-$14.78M
2019-09-30-$12.74M
2019-06-30-$13.69M
2019-03-31-$14.27M
2018-12-31-$3.28M
2018-09-30-$10.16M
2018-06-30-$12.09M
2018-03-31-$11.7M
2017-12-31-$15.17M
2017-09-30-$1.07M

Annual Operating Income

DateOperating Income
2025-12-31-$158.37M
2024-12-31-$238.45M
2023-12-31-$89.28M
2022-12-31-$128.94M
2021-12-31-$98.52M
2020-12-31-$71.06M
2019-12-31-$55.47M
2018-12-31-$37.22M
2017-12-31-$19.27M
2016-12-31$1.36M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.